Pilot Projects Program
试点项目计划
基本信息
- 批准号:10630581
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAmerican Heart AssociationAppointmentAreaBasic ScienceBook ChaptersCardiorenal syndromeCardiovascular DiseasesCategoriesCenters of Research ExcellenceClinical ResearchClinical SciencesCommunitiesConflict of InterestDataDevelopmentDisciplineEducationEligibility DeterminationEquityEvaluationExposure toExtramural ActivitiesFacultyFinancial SupportFundingGoalsGrantGrant ReviewHealthIndividualInternationalJournalsMedical centerMentorsMetabolic DiseasesMississippiPaperPhasePilot ProjectsPopulation ResearchProgram Research Project GrantsPublishingResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProposalsResourcesReview CommitteeScientistSeriesServicesStudy SectionTestingUnited StatesUnited States National Institutes of HealthUniversitiesbasecareerethnic diversityexperiencegender diversityimprovedinnovationmeetingsmembermid-career facultymultidisciplinarynext generationnovelprogramssatisfactionsuccesstranslational potential
项目摘要
PILOT PROJECTS PROGRAM
SUMMARY/ABSTRACT
The Cardiorenal and Metabolic Diseases Research Center (CMDRC) at the University of Mississippi Medical
Center (UMMC) developed a highly successful Pilot Projects Program (PPP) during Phases 1 and 2 of COBRE
support. Over the past 9 years, the CMDRC PPP has provided funding, mentoring, core services, and
enhanced research infrastructure for 24 pilot grant investigators. The success of this program is highlighted by
~$26.92 million dollars in extramural funding obtained by previous PPP awardees as well as 459 papers
published in leading journals in the field, 15 book chapters and 286 presentations at international and national
meetings. To amplify the research base developed in Phases 1 and 2, the Phase 3 PPP will continue to
support innovative research in the areas of cardiorenal and metabolic diseases. The PPP has four specific
aims to achieve these goals: 1) To enhance the PPP developed during Phases 1 and 2, with continued
emphasis on soliciting and identifying a diverse group of promising investigators whose research focuses on
cardiorenal and metabolic diseases for mentoring and funding to expand the critical mass of extramurally
funded CMDRC investigators; 2) To provide rigorous ongoing evaluation of the progress of individual PPP
awardees and the overall PPP to maximize the impact on the investigators mentored and funded through this
program; 3) To facilitate formation of new collaborative, multidisciplinary teams of investigators whose
complementary expertise catalyzes the development of translational projects that result in competitive, cutting-
edge multi-PI proposals for extramural funding; 4) To increase the critical mass of investigators in cardiorenal
and metabolic diseases research at UMMC and to provide mentoring and funding to increase their
competiveness for conducting extramurally funded basic, clinical and population research. Thus, the PPP in
Phase 3 will continue to provide mentoring as well as financial and developmental support for innovative
cardiorenal and metabolic diseases projects to further increase the number and diversity of funded CMDRC
researchers.
试点项目计划
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID E STEC其他文献
DAVID E STEC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID E STEC', 18)}}的其他基金
Project 1 - Role of Bilirubin in Protection against Cardiometabolic Syndrome in Obesity
项目 1 - 胆红素在预防肥胖症心脏代谢综合征中的作用
- 批准号:
9573136 - 财政年份:
- 资助金额:
$ 38.75万 - 项目类别:
相似海外基金
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
8585218 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
9328116 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Center for Regulatory Science (A-TRAC) 2.0
美国心脏协会烟草监管科学中心 (A-TRAC) 2.0
- 批准号:
10246435 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Center for Regulatory Science (A-TRAC) 2.0
美国心脏协会烟草监管科学中心 (A-TRAC) 2.0
- 批准号:
10017285 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
9133442 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Center for Regulatory Science (A-TRAC) 2.0
美国心脏协会烟草监管科学中心 (A-TRAC) 2.0
- 批准号:
10219710 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
8737954 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Regulation and Addiction Center (A-TRAC)
美国心脏协会烟草管制和成瘾中心 (A-TRAC)
- 批准号:
8906919 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
American Heart Association Tobacco Center for Regulatory Science (A-TRAC) 2.0
美国心脏协会烟草监管科学中心 (A-TRAC) 2.0
- 批准号:
10474438 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别: